C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/18 (2006.01) A61K 39/29 (2006.01) C07K 1/22 (2006.01) C12N 15/40 (2006.01) G01N 33/50 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2288374
Methods for obtaining recombinantly produced, C-terminally truncated, E1 and E2 polypeptides from cell lysates are disclosed. The intracellularly expressed truncated molecules display improved biological properties as compared to their secreted counterparts.
On décrit des procédés qui permettent de produire des polypeptides E1 et E2 tronqués à leur extrémité C-terminale, obtenus par recombinaison à partir de lysats cellulaires. Les molécules tronquées exprimées au niveau intracellulaire présentent des propriétés biologiques améliorées par comparaison avec leurs homologues secrétées.
Abrignani Sergio
Chien David
Choo Qui-Lim
Glazer Edward
Houghton Michael
Borden Ladner Gervais Llp
Chiron Corporation
Novartis Vaccines And Diagnostics Inc.
LandOfFree
Intracellular production of hepatitis c e1 and e2 truncated... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intracellular production of hepatitis c e1 and e2 truncated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intracellular production of hepatitis c e1 and e2 truncated... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1342448